Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05423353
Other study ID # Van YYÜ School of Medicine
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 25, 2022
Est. completion date October 19, 2022

Study information

Verified date November 2022
Source Yuzuncu Yil University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is no study in the literature comparing both paraffin bath therapy and Extracorporeal Shock Wave Therapy (ESWT) in the treatment of patients with De Quervain Tenosynovitis. The aim of this study is performing this comparison.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date October 19, 2022
Est. primary completion date September 5, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Being 18 years or older - Meeting De Quervain diagnostic criteria - Not having applied any physical therapy modality to the hand-wrist in the last 1 month - Not using pain medication in the last 1 month, - Not using local anesthetics or steroid injections on the hand-wrist in the last 3 months - Have received written consent to participate in the study, and have come to the last control at the 6th week. Exclusion Criteria: - Neurological diseases (especially neuropathies), - Malignancy, - Rheumatological diseases - Pregnancy - History of hand/wrist fracture or surgery - Hand/wrist trauma in the last 1 month - Coagulation disorder diseases

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Paraffin Bath Therapy
Device named 'Fizyowax 1300' (Fizyomed, Turkey).
Extracorporeal Shock Wave Therapy
Device named 'Elettronica Pagani,Italy' and will be used with radial probe.

Locations

Country Name City State
Turkey Yuzuncu Yil University Van

Sponsors (1)

Lead Sponsor Collaborator
Yuzuncu Yil University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Analogue Scale (VAS) patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse at baseline (before the treatment)
Primary Visual Analogue Scale (VAS) patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse 2 weeks after baseline (at the end of treatment)
Primary Visual Analogue Scale (VAS) patient's self-assessment of pain, in the range of 0 to 10, higher scores mean a worse 6 weeks after baseline (one month after the end of treatment)
Primary Duruöz Hand Index (DHI) Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90. at baseline (before the treatment)
Primary Duruöz Hand Index (DHI) Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90. 2 weeks after baseline (at the end of treatment)
Primary Duruöz Hand Index (DHI) Duruöz Hand Index (DHI) is a functional disability scale that can be used successfully to assess the functional disability with different hand arthropathies. It consists of 18 items that evaluate hand and wrist activities. The answers are evaluated on a 6-level (0-5) Likert scale and the total score ranges from 0 to 90. 6 weeks after baseline (one month after the end of treatment)
See also
  Status Clinical Trial Phase
Completed NCT05692583 - Correlation Between EPB Entrapment Test and Ultrasound Wrist Findings in Patients With deQuervain's Disease
Recruiting NCT05261737 - Steroid Injection in De Quervain Tenosynovitis
Completed NCT05141799 - Effectiveness of High-intensity Laser Therapy in De Quervain Tenosynovitis N/A
Completed NCT05423223 - Comparative Effects of Paraffin Bath Therapy and ESWT on Quality of Life and Sleep in De Quervain Tenosynovitis N/A
Not yet recruiting NCT06012097 - Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease Phase 4
Completed NCT04384536 - Evaluation of Effectiveness of Local Anesthetic Injection in Patients With De Quervain Tenosynovitis N/A
Completed NCT04260984 - Effect of Ultrasound-guided Corticosteroid Injection Versus Palpation-guided Injection for de Quervain's Disease N/A
Recruiting NCT06296472 - De Quervain's Disease in the Acute Phase:a Study Aimed at Evaluating the Effectiveness of Standard Physiotherapy Treatment (HANDGUIDE), Compared to Experimental Treatment After Performing Ultrasound-guided Infiltrative Therapy. N/A
Terminated NCT02029235 - Post-operative Analgesia in Elective, Soft-tissue Hand Surgery Phase 4
Terminated NCT04069741 - Treating Depression in Patients With De Quervain's Tenosynovitis; An Integrated Web Based Skills Intervention N/A
Completed NCT03111186 - Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery Phase 2
Not yet recruiting NCT05782114 - Efficacy of Extracorporeal Shockwave Therapy on Ultrasonographic Changes in de Quervain Tenosynovitis N/A